6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients (2011)
Hidalgo, Maria Paz Loayza; Caumo, Wolnei; Dantas, Giovana; Franco, Daiane Gil; Torres, Iraci Lucena da Silva; Pezzi, Julio; Elisabetsky, Elaine; Detanico, Bernardo Carraro; Piato, Ângelo; Markus, Regina P 
Fonte: Human Psychopharmacology-Clinical and Experimental. Unidade: IB
Assuntos: MELATONINA, DEPRESSÃO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIDALGO, Maria Paz Loayza et al. 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients. Human Psychopharmacology-Clinical and Experimental, v. 26, n. 3, p. 252-257, 2011Tradução . . Disponível em: https://doi.org/10.1002/hup.1204. Acesso em: 03 out. 2024.APA
Hidalgo, M. P. L., Caumo, W., Dantas, G., Franco, D. G., Torres, I. L. da S., Pezzi, J., et al. (2011). 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients. Human Psychopharmacology-Clinical and Experimental, 26( 3), 252-257. doi:10.1002/hup.1204NLM
Hidalgo MPL, Caumo W, Dantas G, Franco DG, Torres IL da S, Pezzi J, Elisabetsky E, Detanico BC, Piato Â, Markus RP. 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients [Internet]. Human Psychopharmacology-Clinical and Experimental. 2011 ; 26( 3): 252-257.[citado 2024 out. 03 ] Available from: https://doi.org/10.1002/hup.1204Vancouver
Hidalgo MPL, Caumo W, Dantas G, Franco DG, Torres IL da S, Pezzi J, Elisabetsky E, Detanico BC, Piato Â, Markus RP. 6-Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients [Internet]. Human Psychopharmacology-Clinical and Experimental. 2011 ; 26( 3): 252-257.[citado 2024 out. 03 ] Available from: https://doi.org/10.1002/hup.1204
